Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pearl millet grain ethanol extract is an ethanol-based extract derived from the grains of *Pennisetum glaucum* (pearl millet). It contains a rich spectrum of bioactive compounds, notably phenolics (e.g., coumarins, flavonoids, tannins, steroids), with proven **anti-hyperlipidemic, hypoglycemic, hepatoprotective, and anti-inflammatory effects** in animal models. The extract works mainly by modulating metabolic and inflammatory pathways, likely through inhibition of carbolytic enzymes (e.g., α-glucosidase), reduction of gluconeogenesis, improvement of insulin resistance, reduction of pro-inflammatory cytokines (IL-6, TNF-α, CRP), and antioxidant activity. Pearl millet polyphenols are posited to regulate glucose transporters (GLUT) and lipid metabolism, contributing to dose-dependent reductions in body weight, serum triglycerides, cholesterol, and blood glucose in rodents fed a high-fat diet[1][3][5][9]. This extract is being investigated for functional food, nutraceutical, and potential therapeutic applications related to metabolic and liver diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pearl millet grain ethanol extract.